Current Research Studies

Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD (COMPARE)

COMPARE

Phase: N/A
Clinicaltrials.gov ID: NCT07198113

What is the goal of the study?

The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). COMPARE will consist of two multicenter, prospective observational cohorts (1 for patients with Crohn’s disease [CD] and 1 for patients with ulcerative colitis [UC] or IBD-unspecified [IBD-U]) along with a retrospective cohort analysis focused on the long-term safety of these newer therapies.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Timothy Adamos
Study Team Member: Cylia Abrous, [email protected]